相关实验视频

Updated: Jun 4, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

在非转移性乳腺癌中,FDG PETCT对新辅助化疗反应有预测价值吗?

Ender Dogan¹, Safak Yildirim Disli², Esra Asik³

¹Department of Medical Oncology, Kayseri City Education and Training Hospital, Kayseri, Turkey. enderdogandr1@gmail.com.

Irish journal of medical science

|December 18, 2024

概括

从基线PET-CT扫描中获得的最大标准化吸收值 (SUVmax) 可能有助于预测早期乳腺癌患者对新辅助化疗的病理完整反应 (pCR). 较高的SUVmax值显示出更好的响应趋势,表明其作为预测因素的潜力.

科学领域:

在瘤学瘤学.
医疗成像医学成像
核医学就是核医学.

背景情况:

在新辅助化疗 (NAC) 后的病理完整反应 (pCR) 对早期乳腺癌预后至关重要.
预测NAC反应对于优化新辅助治疗策略至关重要.

研究的目的:

评估基线F-18氧化葡萄糖 (FDG) 定子发射断层扫描/计算机断层扫描 (PET-CT) SUVmax在早期乳腺癌中NAC后的pCR的预测能力.
为了确定基线PET-CTSUVmax是否可以作为治疗反应的生物标志物.

主要方法:

对148名乳腺癌早期患者的回顾性分析,这些患者在NAC之前接受了PET-CT.
基线PET-CTSUVmax值的分类为低 (截止值<8.77) 和高 (截止值≥8.77) 组.
后勤回归分析,以评估SUVmax对pCR的影响.

主要成果:

高SUVmax组与低SUVmax组相比,显示了较高的pCR率的趋势 (p=0.052).
基线PET-CTSUVmax被确定为PCR的独立预测因子 (p=0.025).

结论:

基线PET-CTSUVmax显示,在接受NAC.CT的早期乳腺癌患者中实现pCR的预测因子具有潜力.
进一步的研究可能会验证SUVmax作为指导新辅助治疗决策的生物标志物.

关键词:

乳腺癌是什么? 乳腺癌是什么?完成一个完整的响应.新辅助治疗新辅助治疗

更多相关视频

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...